References and Further Reading
Collins, L. C., & Schnitt, S. (2013). Biopsy interpretation of the breast (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.
Geyer, F. C., Weigelt, B., Natrajan, R., Lambros, M. B., de Biase, D., Vatcheva, R., Savage, K., Mackay, A., Ashworth, A., & Reis-Filho, J. S. (2010). Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. The Journal of Pathology, 220(5), 562ā573.
Gobbi, H., Simpson, J. F., Borowsky, A., Jensen, R. A., & Page, D. L. (1999). Metaplastic breast tumors with a dominant fibromatosis-like phenotype have a high risk of local recurrence. Cancer, 85(10), 2170ā2182.
Gobbi, H., Simpson, J. F., Jensen, R. A., Olson, S. J., & Page, D. L. (2003). Metaplastic spindle cell breast tumors arising within papillomas, complex sclerosing lesions, and nipple adenomas. Modern Pathology, 16(9), 893ā901.
Hattori, Y., Yoshida, A., Yoshida, M., Takahashi, M., & Tsuta, K. (2015). Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung. Pathology International, 65(6), 286ā292.
Hennessy, B. T., Gonzalez-Angulo, A. M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J. S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., Liu, W., Stivers, D., Baggerly, K., Carey, M., Lluch, A., Monteagudo, C., He, X., Weigman, V., Fan, C., Palazzo, J., Hortobagyi, G. N., Nolden, L. K., Wang, N. J., Valero, V., Gray, J. W., Perou, C. M., & Mills, G. B. (2009). Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Research, 69(10), 4116ā4124.
Jung, S. Y., Kim, H. Y., Nam, B. H., Min, S. Y., Lee, S. J., Park, C., Kwon, Y., Kim, E. A., Ko, K. L., Shin, K. H., Lee, K. S., Park, I. H., Lee, S., Kim, S. W., Kang, H. S., & Ro, J. (2010). Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Research and Treatment, 120(3), 627ā637.
Lai, H. W., Tseng, L. M., Chang, T. W., Kuo, Y. L., Hsieh, C. M., Chen, S. T., Kuo, S. J., Su, C. C., & Chen, D. R. (2013). The prognostic significance of metaplastic carcinoma of the breast (MCB)āA case controlled comparison study with infiltrating ductal carcinoma. Breast, 22(5), 968ā973.
Lakhani, S. R., Ellis, I. O., Schnitt, S. R., Hoon Tan, P., & van de Vijver, M. (2012). WHO classification of tumors of the breast. Lyon: IARC Press.
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011). Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. Journal of Clinical Investigation, 121(7), 2750ā2767.
Lehmann, B. D., JovanoviÄ, B., Chen, X., Estrada, M. V., Johnson, K. N., Shyr, Y., Moses, H. L., Sanders, M. E., & Pietenpol, J. A. (2016). Refinement of triple-negative breast cancer molecular subtypes: Implications for neoadjuvant chemotherapy selection. PLoS One, 11(6), e0157368.
Lien, H. C., Lin, C. W., Mao, T. L., Kuo, S. H., Hsiao, C. H., & Huang, C. S. (2004). p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. The Journal of Pathology, 204(2), 131ā139.
Marchio, C., Geyer, F. C., & Reis-Filho, J. S. (2016). Pathology and molecular pathology of breast cancer. In M. Loda et al. (Eds.), Pathology and epidemiology of cancer (pp. 173ā232). Cham: Springer International Publishing.
Ng, C. K. Y., Piscuoglio, S., Geyer, F. C., Burke, K. A., Pareja, F., Eberle, C. A., Lim, R. S., Natrajan, R., Riaz, N., Mariani, O., Norton, L., Vincent-Salomon, A., Wen, Y. H., Weigelt, B., & Reis-Filho, J. S. (2017). The landscape of somatic genetic alterations in metaplastic breast carcinomas. Clinical Cancer Research, 23(14), 3859ā3870.
Pezzi, C. M., Patel-Parekh, L., Cole, K., Franko, J., Klimberg, V. S., & Bland, K. (2007). Characteristics and treatment of metaplastic breast cancer: Analysis of 892 cases from the National Cancer Data Base. Annals of Surgical Oncology, 14(1), 166ā173.
Tanabe, Y., Tsuda, H., Yoshida, M., Yunokawa, M., Yonemori, K., Shimizu, C., Yamamoto, S., Kinoshita, T., Fujiwara, Y., & Tamura, K. (2017). Pathological features of triple-negative breast cancers that showed progressive disease during neoadjuvant chemotherapy. Cancer Science, 108(7), 1520ā1529.
Provenzano, E., Byrne, D. J., Russell, P. A., Wright, G. M., Generali, D., & Fox, S. B. (2016). Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours. Histopathology, 68(3), 367ā377.
Rakha, E. A., Aleskandarany, M. A., Lee, A. H., & Ellis, I. O. (2016). An approach to the diagnosis of spindle cell lesions of the breast. Histopathology, 68(1), 33ā44.
Rakha, E. A., Coimbra, N. D., Hodi, Z., Juneinah, E., Ellis, I. O., & Lee, A. H. (2017). Immunoprofile of metaplastic carcinomas of the breast. Histopathology, 70(6), 975ā985.
Reis-Filho, J. S., Milanezi, F., Steele, D., Savage, K., Simpson, P. T., Nesland, J. M., Pereira, E. M., Lakhani, S. R., & Schmitt, F. C. (2006). Metaplastic breast carcinomas are basal-like tumours. Histopathology, 49(1), 10ā21.
Reyes, C., Gomez-FernĆ”ndez, C., & Nadji, M. (2012). Metaplastic and medullary mammary carcinomas do not express mammaglobin. American Journal of Clinical Pathology, 137(5), 747ā752.
Sneige, N., Yaziji, H., Mandavilli, S. R., Perez, E. R., Ordonez, N. G., Gown, A. M., & Ayala, A. (2001). Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. American Journal of Surgical Pathology, 25(8), 1009ā1016.
Weigelt, B., Kreike, B., & Reis-Filho, J. S. (2009). Metaplastic breast carcinomas are basal-like breast cancers: A genomic profiling analysis. Breast Cancer Research and Treatment, 117(2), 273ā280.
Weigelt, B., Ng, C. K., Shen, R., Popova, T., Schizas, M., Natrajan, R., Mariani, O., Stern, M. H., Norton, L., Vincent-Salomon, A., & Reis-Filho, J. S. (2015). Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity. Modern Pathology, 28(3), 340ā351.
Wendroth, S. M., Mentrikoski, M. J., & Wick, M. R. (2015). GATA3 expression in morphologic subtypes of breast carcinoma: A comparison with gross cystic disease fluid protein 15 and mammaglobin. Annals of Diagnostic Pathology, 19(1), 6ā9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
MarchiĆ², C., Chartier, S., Bataillon, G., Vincent-Salomon, A. (2019). Invasive Metaplastic Carcinoma. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_4717-2
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_4717-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Invasive Metaplastic Carcinoma- Published:
- 26 November 2018
DOI: https://doi.org/10.1007/978-3-319-28845-1_4717-2
-
Original
Invasive Metaplastic Carcinoma- Published:
- 22 March 2018
DOI: https://doi.org/10.1007/978-3-319-28845-1_4717-1